APO Research
Talk to an analyst

APO RESEARCH · REPORT

Bronchitis Drug

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Bronchitis Drug Industry Growth and Trends Forecast to 2032

22 December 2025108 pages

Choose your research edition.

Industry ResearchBronchitis Drug Industry Research Report 2026126 pages · $2,950 USDIndustry Growth & TrendsGlobal Bronchitis Drug Industry Growth and Trends Forecast to 2032108 pages · $3,450 USDMarket StructureGlobal Bronchitis Drug Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032198 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Bronchitis Drug Market Outlook and Growth Opportunities 2026190 pages · $4,250 USDMarket Analysis & ForecastGlobal Bronchitis Drug Market Analysis and Forecast 2026-2032192 pages · $4,950 USD

Market perspective

The global Bronchitis Drug market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Bronchitis Drug is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Bronchitis Drug is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Bronchitis Drug is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Bronchitis Drug include Merck & Co Inc, AstraZeneca Plc, Therabron Therapeutics Inc, Orbis Biosciences Inc, Mucosis BV, Kyorin Pharmaceutical Co Ltd, Han Wha Pharma Co Ltd, F. Hoffmann-La Roche Ltd and DBV Technologies SA, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Bronchitis Drug market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Bronchitis Drug market size, estimates, and forecasts are presented in terms of sales volume (k units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Bronchitis Drug market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Bronchitis Drug.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Bronchitis Drug market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Bronchitis Drug Market by Company

Merck & Co Inc

AstraZeneca Plc

Therabron Therapeutics Inc

Orbis Biosciences Inc

Mucosis BV

Kyorin Pharmaceutical Co Ltd

Han Wha Pharma Co Ltd

F. Hoffmann-La Roche Ltd

DBV Technologies SA

Advanced Inhalation Therapies (AIT) Ltd

Bronchitis Drug Segment by Type

AZD-9668

CG-367

HOB-051

Cyclosporine

Others

Bronchitis Drug Segment by Application

Clinic

Hospital

Homecare

Bronchitis Drug Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Bronchitis Drug market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Bronchitis Drug and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Bronchitis Drug.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Bronchitis Drug manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Bronchitis Drug in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of AZD-9668 Table 2. Major Company of CG-367 Table 3. Major Company of HOB-051 Table 4. Major Company of Cyclosporine Table 5. Major Company of Others Table 6. Global Bronchitis Drug Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 7. Global Bronchitis Drug Sales by Type (2021-2026) & (k units) Table 8. Global Bronchitis Drug Sales Market Share in Volume by Type (2021-2026) Table 9. Global Bronchitis Drug Sales by Type (2021-2026) & (US$ Million) Table 10. Global Bronchitis Drug Sales Market Share in Value by Type (2021-2026) Table 11. Global Bronchitis Drug Price by Type (2021-2026) & (US$/unit) Table 12. Global Bronchitis Drug Sales by Type (2027-2032) & (k units) Table 13. Global Bronchitis Drug Sales Market Share in Volume by Type (2027-2032) Table 14. Global Bronchitis Drug Sales by Type (2027-2032) & (US$ Million) Table 15. Global Bronchitis Drug Sales Market Share in Value by Type (2027-2032) Table 16. Global Bronchitis Drug Price by Type (2027-2032) & (US$/unit) Table 17. North America Bronchitis Drug Sales by Type (2021-2026) & (k units) Table 18. North America Bronchitis Drug Sales by Type (2021-2026) & (US$ Million) Table 19. Europe Bronchitis Drug Sales by Type (2021-2026) & (k units) Table 20. Europe Bronchitis Drug Sales by Type (2021-2026) & (US$ Million) Table 21. Asia-Pacific Bronchitis Drug Sales by Type (2021-2026) & (k units) Table 22. Asia-Pacific Bronchitis Drug Sales by Type (2021-2026) & (US$ Million) Table 23. Latin America Bronchitis Drug Sales by Type (2021-2026) & (k units) Table 24. Latin America Bronchitis Drug Sales by Type (2021-2026) & (US$ Million) Table 25. Middle East and Africa Bronchitis Drug Sales by Type (2021-2026) & (k units) Table 26. Middle East and Africa Bronchitis Drug Sales by Type (2021-2026) & (US$ Million) Table 27. Bronchitis Drug Industry Trends Table 28. Bronchitis Drug Industry Drivers Table 29. Bronchitis Drug Industry Opportunities and Challenges Table 30. Bronchitis Drug Industry Restraints Table 31. Global Bronchitis Drug Sales Revenue by Company (US$ Million) & (2021-2026) Table 32. Global Bronchitis Drug Revenue Market Share by Company (2021-2026) Table 33. Global Bronchitis Drug Sales by Company (2021-2026) & (k units) Table 34. Global Bronchitis Drug Sales Share by Company (2021-2026) Table 35. Global Bronchitis Drug Market Price by Company (2021-2026) & (US$/unit) Table 36. Global Bronchitis Drug Industry Company Ranking, 2024 VS 2025 VS 2026 Table 37. Global Bronchitis Drug Major Company Production Sites and Headquarters Table 38. Global Bronchitis Drug Company, Product Type & Application Table 39. Global Bronchitis Drug Company Establishment Date Table 40. Global Company Market Concentration Ratio (CR5 and HHI) Table 41. Global Bronchitis Drug by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 42. Global Bronchitis Drug Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 43. Global Bronchitis Drug Sales by Region (2021-2026) & (k units) Table 44. Global Bronchitis Drug Sales Market Share in Volume by Region (2021-2026) Table 45. Global Bronchitis Drug Sales by Region (2021-2026) & (US$ Million) Table 46. Global Bronchitis Drug Sales Market Share in Value by Region (2021-2026) Table 47. Global Bronchitis Drug Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 48. Global Bronchitis Drug Sales by Region (2027-2032) & (k units) Table 49. Global Bronchitis Drug Sales Market Share in Volume by Region (2027-2032) Table 50. Global Bronchitis Drug Sales by Region (2027-2032) & (US$ Million) Table 51. Global Bronchitis Drug Sales Market Share in Value by Region (2027-2032) Table 52. Global Bronchitis Drug Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2027-2032) Table 53. Global Bronchitis Drug Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 54. Global Bronchitis Drug Sales by Application (2021-2026) & (k units) Table 55. Global Bronchitis Drug Sales Market Share in Volume by Application (2021-2026) Table 56. Global Bronchitis Drug Sales by Application (2021-2026) & (US$ Million) Table 57. Global Bronchitis Drug Sales Market Share in Value by Application (2021-2026) Table 58. Global Bronchitis Drug Price by Application (2021-2026) & (US$/unit) Table 59. Global Bronchitis Drug Sales by Application (2027-2032) & (k units) Table 60. Global Bronchitis Drug Sales Market Share in Volume by Application (2027-2032) Table 61. Global Bronchitis Drug Sales by Application (2027-2032) & (US$ Million) Table 62. Global Bronchitis Drug Sales Market Share in Value by Application (2027-2032) Table 63. Global Bronchitis Drug Price by Application (2027-2032) & (US$/unit) Table 64. North America Bronchitis Drug Sales by Application (2021-2026) & (k units) Table 65. North America Bronchitis Drug Sales by Application (2021-2026) & (US$ Million) Table 66. Europe Bronchitis Drug Sales by Application (2021-2026) & (k units) Table 67. Europe Bronchitis Drug Sales by Application (2021-2026) & (US$ Million) Table 68. Asia-Pacific Bronchitis Drug Sales by Application (2021-2026) & (k units) Table 69. Asia-Pacific Bronchitis Drug Sales by Application (2021-2026) & (US$ Million) Table 70. Latin America Bronchitis Drug Sales by Application (2021-2026) & (k units) Table 71. Latin America Bronchitis Drug Sales by Application (2021-2026) & (US$ Million) Table 72. Middle East and Africa Bronchitis Drug Sales by Application (2021-2026) & (k units) Table 73. Middle East and Africa Bronchitis Drug Sales by Application (2021-2026) & (US$ Million) Table 74. Merck & Co Inc Company Information Table 75. Merck & Co Inc Business Overview Table 76. Merck & Co Inc Bronchitis Drug Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 77. Merck & Co Inc Bronchitis Drug Product Portfolio Table 78. Merck & Co Inc Recent Development Table 79. AstraZeneca Plc Company Information Table 80. AstraZeneca Plc Business Overview Table 81. AstraZeneca Plc Bronchitis Drug Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 82. AstraZeneca Plc Bronchitis Drug Product Portfolio Table 83. AstraZeneca Plc Recent Development Table 84. Therabron Therapeutics Inc Company Information Table 85. Therabron Therapeutics Inc Business Overview Table 86. Therabron Therapeutics Inc Bronchitis Drug Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 87. Therabron Therapeutics Inc Bronchitis Drug Product Portfolio Table 88. Therabron Therapeutics Inc Recent Development Table 89. Orbis Biosciences Inc Company Information Table 90. Orbis Biosciences Inc Business Overview Table 91. Orbis Biosciences Inc Bronchitis Drug Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 92. Orbis Biosciences Inc Bronchitis Drug Product Portfolio Table 93. Orbis Biosciences Inc Recent Development Table 94. Mucosis BV Company Information Table 95. Mucosis BV Business Overview Table 96. Mucosis BV Bronchitis Drug Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 97. Mucosis BV Bronchitis Drug Product Portfolio Table 98. Mucosis BV Recent Development Table 99. Kyorin Pharmaceutical Co Ltd Company Information Table 100. Kyorin Pharmaceutical Co Ltd Business Overview Table 101. Kyorin Pharmaceutical Co Ltd Bronchitis Drug Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 102. Kyorin Pharmaceutical Co Ltd Bronchitis Drug Product Portfolio Table 103. Kyorin Pharmaceutical Co Ltd Recent Development Table 104. Han Wha Pharma Co Ltd Company Information Table 105. Han Wha Pharma Co Ltd Business Overview Table 106. Han Wha Pharma Co Ltd Bronchitis Drug Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 107. Han Wha Pharma Co Ltd Bronchitis Drug Product Portfolio Table 108. Han Wha Pharma Co Ltd Recent Development Table 109. F. Hoffmann-La Roche Ltd Company Information Table 110. F. Hoffmann-La Roche Ltd Business Overview Table 111. F. Hoffmann-La Roche Ltd Bronchitis Drug Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 112. F. Hoffmann-La Roche Ltd Bronchitis Drug Product Portfolio Table 113. F. Hoffmann-La Roche Ltd Recent Development Table 114. DBV Technologies SA Company Information Table 115. DBV Technologies SA Business Overview Table 116. DBV Technologies SA Bronchitis Drug Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 117. DBV Technologies SA Bronchitis Drug Product Portfolio Table 118. DBV Technologies SA Recent Development Table 119. Advanced Inhalation Therapies (AIT) Ltd Company Information Table 120. Advanced Inhalation Therapies (AIT) Ltd Business Overview Table 121. Advanced Inhalation Therapies (AIT) Ltd Bronchitis Drug Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 122. Advanced Inhalation Therapies (AIT) Ltd Bronchitis Drug Product Portfolio Table 123. Advanced Inhalation Therapies (AIT) Ltd Recent Development Table 124. North America Bronchitis Drug Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 125. North America Bronchitis Drug Sales by Country (2021-2026) & (k units) Table 126. North America Bronchitis Drug Sales Market Share by Country (2021-2026) Table 127. North America Bronchitis Drug Sales Forecast by Country (2027-2032) & (k units) Table 128. North America Bronchitis Drug Sales Market Share Forecast by Country (2027-2032) Table 129. North America Bronchitis Drug Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 130. North America Bronchitis Drug Market Size by Country (2021-2026) & (US$ Million) Table 131. North America Bronchitis Drug Market Share by Country (2021-2026) Table 132. North America Bronchitis Drug Market Size Forecast by Country (2027-2032) & (US$ Million) Table 133. North America Bronchitis Drug Market Share Forecast by Country (2027-2032) Table 134. Europe Bronchitis Drug Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 135. Europe Bronchitis Drug Sales by Country (2021-2026) & (k units) Table 136. Europe Bronchitis Drug Sales Market Share by Country (2021-2026) Table 137. Europe Bronchitis Drug Sales Forecast by Country (2027-2032) & (k units) Table 138. Europe Bronchitis Drug Sales Market Share Forecast by Country (2027-2032) Table 139. Europe Bronchitis Drug Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 140. Europe Bronchitis Drug Market Size by Country (2021-2026) & (US$ Million) Table 141. Europe Bronchitis Drug Market Share by Country (2021-2026) Table 142. Europe Bronchitis Drug Market Size Forecast by Country (2027-2032) & (US$ Million) Table 143. Europe Bronchitis Drug Market Share Forecast by Country (2027-2032) Table 144. Asia-Pacific Bronchitis Drug Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 145. Asia-Pacific Bronchitis Drug Sales by Country (2021-2026) & (k units) Table 146. Asia-Pacific Bronchitis Drug Sales Market Share by Country (2021-2026) Table 147. Asia-Pacific Bronchitis Drug Sales Forecast by Country (2027-2032) & (k units) Table 148. Asia-Pacific Bronchitis Drug Sales Market Share Forecast by Country (2027-2032) Table 149. Asia-Pacific Bronchitis Drug Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 150. Asia-Pacific Bronchitis Drug Market Size by Country (2021-2026) & (US$ Million) Table 151. Asia-Pacific Bronchitis Drug Market Share by Country (2021-2026) Table 152. Asia-Pacific Bronchitis Drug Market Size Forecast by Country (2027-2032) & (US$ Million) Table 153. Asia-Pacific Bronchitis Drug Market Share Forecast by Country (2027-2032) Table 154. Latin America Bronchitis Drug Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 155. Latin America Bronchitis Drug Sales by Country (2021-2026) & (k units) Table 156. Latin America Bronchitis Drug Sales Market Share by Country (2021-2026) Table 157. Latin America Bronchitis Drug Sales Forecast by Country (2027-2032) & (k units) Table 158. Latin America Bronchitis Drug Sales Market Share Forecast by Country (2027-2032) Table 159. Latin America Bronchitis Drug Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 160. Latin America Bronchitis Drug Market Size by Country (2021-2026) & (US$ Million) Table 161. Latin America Bronchitis Drug Market Share by Country (2021-2026) Table 162. Latin America Bronchitis Drug Market Size Forecast by Country (2027-2032) & (US$ Million) Table 163. Latin America Bronchitis Drug Market Share Forecast by Country (2027-2032) Table 164. Middle East and Africa Bronchitis Drug Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 165. Middle East and Africa Bronchitis Drug Sales by Country (2021-2026) & (k units) Table 166. Middle East and Africa Bronchitis Drug Sales Market Share by Country (2021-2026) Table 167. Middle East and Africa Bronchitis Drug Sales Forecast by Country (2027-2032) & (k units) Table 168. Middle East and Africa Bronchitis Drug Sales Market Share Forecast by Country (2027-2032) Table 169. Middle East and Africa Bronchitis Drug Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 170. Middle East and Africa Bronchitis Drug Market Size by Country (2021-2026) & (US$ Million) Table 171. Middle East and Africa Bronchitis Drug Market Share by Country (2021-2026) Table 172. Middle East and Africa Bronchitis Drug Market Size Forecast by Country (2027-2032) & (US$ Million) Table 173. Middle East and Africa Bronchitis Drug Market Share Forecast by Country (2027-2032) Table 174. Key Raw Materials Table 175. Raw Materials Key Suppliers Table 176. Bronchitis Drug Distributors List Table 177. Bronchitis Drug Customers List Table 178. Research Programs/Design for This Report Table 179. Authors List of This Report Table 180. Secondary Sources Table 181. Primary Sources List of Figures Figure 1. Bronchitis Drug Image Figure 2. Global Bronchitis Drug Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Bronchitis Drug Market Size (2021-2032) & (US$ Million) Figure 4. Global Bronchitis Drug Sales (2021-2032) & (k units) Figure 5. AZD-9668 Image Figure 6. Global AZD-9668 Sales YoY Growth (2021-2032) & (k units) Figure 7. CG-367 Image Figure 8. Global CG-367 Sales YoY Growth (2021-2032) & (k units) Figure 9. HOB-051 Image Figure 10. Global HOB-051 Sales YoY Growth (2021-2032) & (k units) Figure 11. Cyclosporine Image Figure 12. Global Cyclosporine Sales YoY Growth (2021-2032) & (k units) Figure 13. Others Image Figure 14. Global Others Sales YoY Growth (2021-2032) & (k units) Figure 15. Global Bronchitis Drug Market Size Overview by Type (2021-2032) & (US$ Million) Figure 16. Global Bronchitis Drug Market Share by Type 2025 VS 2032 Figure 17. North America Bronchitis Drug Sales Market Share in Volume by Type in 2025 Figure 18. North America Bronchitis Drug Sales Market Share in Value by Type in 2025 Figure 19. Europe Bronchitis Drug Sales Market Share in Volume by Type in 2025 Figure 20. Europe Bronchitis Drug Sales Market Share in Value by Type in 2025 Figure 21. Asia-Pacific Bronchitis Drug Sales Market Share in Volume by Type in 2025 Figure 22. Asia-Pacific Bronchitis Drug Sales Market Share in Value by Type in 2025 Figure 23. Latin America Bronchitis Drug Sales Market Share in Volume by Type in 2025 Figure 24. Latin America Bronchitis Drug Sales Market Share in Value by Type in 2025 Figure 25. Middle East and Africa Bronchitis Drug Sales Market Share in Volume by Type in 2025 Figure 26. Middle East and Africa Bronchitis Drug Sales Market Share in Value by Type in 2025 Figure 27. Global Top 5 and 10 Bronchitis Drug Players Market Share by Revenue in 2025 Figure 28. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 29. Clinic Image Figure 30. Global Clinic Sales YoY Growth (2021-2032) & (k units) Figure 31. Hospital Image Figure 32. Global Hospital Sales YoY Growth (2021-2032) & (k units) Figure 33. Homecare Image Figure 34. Global Homecare Sales YoY Growth (2021-2032) & (k units) Figure 35. Global Bronchitis Drug Market Size Overview by Application (2021-2032) & (US$ Million) Figure 36. Global Bronchitis Drug Market Share by Application 2025 VS 2032 Figure 37. North America Bronchitis Drug Sales Market Share in Volume by Application in 2025 Figure 38. North America Bronchitis Drug Sales Market Share in Value by Application in 2025 Figure 39. Europe Bronchitis Drug Sales Market Share in Volume by Application in 2025 Figure 40. Europe Bronchitis Drug Sales Market Share in Value by Application in 2025 Figure 41. Asia-Pacific Bronchitis Drug Sales Market Share in Volume by Application in 2025 Figure 42. Asia-Pacific Bronchitis Drug Sales Market Share in Value by Application in 2025 Figure 43. Latin America Bronchitis Drug Sales Market Share in Volume by Application in 2025 Figure 44. Latin America Bronchitis Drug Sales Market Share in Value by Application in 2025 Figure 45. Middle East and Africa Bronchitis Drug Sales Market Share in Volume by Application in 2025 Figure 46. Middle East and Africa Bronchitis Drug Sales Market Share in Value by Application in 2025 Figure 47. North America Bronchitis Drug Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 48. North America Bronchitis Drug Sales Share by Country: 2021 VS 2025 VS 2032 Figure 49. North America Bronchitis Drug Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 50. North America Bronchitis Drug Market Share by Country: 2021 VS 2025 VS 2032 Figure 51. Europe Bronchitis Drug Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 52. Europe Bronchitis Drug Sales Share by Country: 2021 VS 2025 VS 2032 Figure 53. Europe Bronchitis Drug Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 54. Europe Bronchitis Drug Market Share by Country: 2021 VS 2025 VS 2032 Figure 55. Asia-Pacific Bronchitis Drug Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 56. Asia-Pacific Bronchitis Drug Sales Share by Country: 2021 VS 2025 VS 2032 Figure 57. Asia-Pacific Bronchitis Drug Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Asia-Pacific Bronchitis Drug Market Share by Country: 2021 VS 2025 VS 2032 Figure 59. Latin America Bronchitis Drug Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 60. Latin America Bronchitis Drug Sales Share by Country: 2021 VS 2025 VS 2032 Figure 61. Latin America Bronchitis Drug Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 62. Latin America Bronchitis Drug Market Share by Country: 2021 VS 2025 VS 2032 Figure 63. Middle East and Africa Bronchitis Drug Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 64. Middle East and Africa Bronchitis Drug Sales Share by Country: 2021 VS 2025 VS 2032 Figure 65. Middle East and Africa Bronchitis Drug Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 66. Middle East and Africa Bronchitis Drug Market Share by Country: 2021 VS 2025 VS 2032 Figure 67. Bronchitis Drug Value Chain Figure 68. Key Raw Materials Price Figure 69. Manufacturing Cost Structure Figure 70. Bronchitis Drug Production Mode & Process Figure 71. Direct Comparison with Distribution Share Figure 72. Distributors Profiles Figure 73. Years Considered Figure 74. Research Process Figure 75. Key Executives Interviewed

Scope & coverage.

Types
  • AZD-9668
  • CG-367
  • HOB-051
  • Cyclosporine
  • Others
Applications
  • Clinic
  • Hospital
  • Homecare
Companies covered
  • Merck & Co Inc
  • AstraZeneca Plc
  • Therabron Therapeutics Inc
  • Orbis Biosciences Inc
  • Mucosis BV
  • Kyorin Pharmaceutical Co Ltd
  • Han Wha Pharma Co Ltd
  • F. Hoffmann-La Roche Ltd
  • DBV Technologies SA
  • Advanced Inhalation Therapies (AIT) Ltd

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Bronchitis Drug Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Bronchitis Drug Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Bronchitis Drug Market by Type
  6. 1.3.1 AZD-9668
  7. 1.3.2 CG-367
  8. 1.3.3 HOB-051
  9. 1.3.4 Cyclosporine
  10. 1.3.5 Others
  11. 1.4 Global Bronchitis Drug Market Size by Type
  12. 1.4.1 Global Bronchitis Drug Market Size Overview by Type (2021-2032)
  13. 1.4.2 Global Bronchitis Drug Historic Market Size Review by Type (2021-2026)
  14. 1.4.3 Global Bronchitis Drug Forecasted Market Size by Type (2027-2032)
  15. 1.5 Key Regions Market Size by Type
  16. 1.5.1 North America Bronchitis Drug Sales Breakdown by Type (2021-2026)
  17. 1.5.2 Europe Bronchitis Drug Sales Breakdown by Type (2021-2026)
  18. 1.5.3 Asia-Pacific Bronchitis Drug Sales Breakdown by Type (2021-2026)
  19. 1.5.4 South America Bronchitis Drug Sales Breakdown by Type (2021-2026)
  20. 1.5.5 Middle East and Africa Bronchitis Drug Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Bronchitis Drug Industry Trends
  2. 2.2 Bronchitis Drug Industry Drivers
  3. 2.3 Bronchitis Drug Industry Opportunities and Challenges
  4. 2.4 Bronchitis Drug Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Bronchitis Drug Revenue (2021-2026)
  2. 3.2 Global Top Players by Bronchitis Drug Sales (2021-2026)
  3. 3.3 Global Top Players by Bronchitis Drug Price (2021-2026)
  4. 3.4 Global Bronchitis Drug Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Bronchitis Drug Major Company Production Sites & Headquarters
  6. 3.6 Global Bronchitis Drug Company, Product Type & Application
  7. 3.7 Global Bronchitis Drug Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Bronchitis Drug Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Bronchitis Drug Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Bronchitis Drug Tier 1, Tier 2, and Tier 3
4 Bronchitis Drug Regional Status and Outlook
  1. 4.1 Global Bronchitis Drug Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Bronchitis Drug Historic Market Size by Region
  3. 4.2.1 Global Bronchitis Drug Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Bronchitis Drug Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Bronchitis Drug Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Bronchitis Drug Forecasted Market Size by Region
  7. 4.3.1 Global Bronchitis Drug Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Bronchitis Drug Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Bronchitis Drug Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Bronchitis Drug by Application
  1. 5.1 Bronchitis Drug Market by Application
  2. 5.1.1 Clinic
  3. 5.1.2 Hospital
  4. 5.1.3 Homecare
  5. 5.2 Global Bronchitis Drug Market Size by Application
  6. 5.2.1 Global Bronchitis Drug Market Size Overview by Application (2021-2032)
  7. 5.2.2 Global Bronchitis Drug Historic Market Size Review by Application (2021-2026)
  8. 5.2.3 Global Bronchitis Drug Forecasted Market Size by Application (2027-2032)
  9. 5.3 Key Regions Market Size by Application
  10. 5.3.1 North America Bronchitis Drug Sales Breakdown by Application (2021-2026)
  11. 5.3.2 Europe Bronchitis Drug Sales Breakdown by Application (2021-2026)
  12. 5.3.3 Asia-Pacific Bronchitis Drug Sales Breakdown by Application (2021-2026)
  13. 5.3.4 South America Bronchitis Drug Sales Breakdown by Application (2021-2026)
  14. 5.3.5 Middle East and Africa Bronchitis Drug Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Merck & Co Inc
  2. 6.1.1 Merck & Co Inc Company Information
  3. 6.1.2 Merck & Co Inc Business Overview
  4. 6.1.3 Merck & Co Inc Bronchitis Drug Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Merck & Co Inc Bronchitis Drug Product Portfolio
  6. 6.1.5 Merck & Co Inc Recent Developments
  7. 6.2 AstraZeneca Plc
  8. 6.2.1 AstraZeneca Plc Company Information
  9. 6.2.2 AstraZeneca Plc Business Overview
  10. 6.2.3 AstraZeneca Plc Bronchitis Drug Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 AstraZeneca Plc Bronchitis Drug Product Portfolio
  12. 6.2.5 AstraZeneca Plc Recent Developments
  13. 6.3 Therabron Therapeutics Inc
  14. 6.3.1 Therabron Therapeutics Inc Company Information
  15. 6.3.2 Therabron Therapeutics Inc Business Overview
  16. 6.3.3 Therabron Therapeutics Inc Bronchitis Drug Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Therabron Therapeutics Inc Bronchitis Drug Product Portfolio
  18. 6.3.5 Therabron Therapeutics Inc Recent Developments
  19. 6.4 Orbis Biosciences Inc
  20. 6.4.1 Orbis Biosciences Inc Company Information
  21. 6.4.2 Orbis Biosciences Inc Business Overview
  22. 6.4.3 Orbis Biosciences Inc Bronchitis Drug Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Orbis Biosciences Inc Bronchitis Drug Product Portfolio
  24. 6.4.5 Orbis Biosciences Inc Recent Developments
  25. 6.5 Mucosis BV
  26. 6.5.1 Mucosis BV Company Information
  27. 6.5.2 Mucosis BV Business Overview
  28. 6.5.3 Mucosis BV Bronchitis Drug Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Mucosis BV Bronchitis Drug Product Portfolio
  30. 6.5.5 Mucosis BV Recent Developments
  31. 6.6 Kyorin Pharmaceutical Co Ltd
  32. 6.6.1 Kyorin Pharmaceutical Co Ltd Company Information
  33. 6.6.2 Kyorin Pharmaceutical Co Ltd Business Overview
  34. 6.6.3 Kyorin Pharmaceutical Co Ltd Bronchitis Drug Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Kyorin Pharmaceutical Co Ltd Bronchitis Drug Product Portfolio
  36. 6.6.5 Kyorin Pharmaceutical Co Ltd Recent Developments
  37. 6.7 Han Wha Pharma Co Ltd
  38. 6.7.1 Han Wha Pharma Co Ltd Company Information
  39. 6.7.2 Han Wha Pharma Co Ltd Business Overview
  40. 6.7.3 Han Wha Pharma Co Ltd Bronchitis Drug Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 Han Wha Pharma Co Ltd Bronchitis Drug Product Portfolio
  42. 6.7.5 Han Wha Pharma Co Ltd Recent Developments
  43. 6.8 F. Hoffmann-La Roche Ltd
  44. 6.8.1 F. Hoffmann-La Roche Ltd Company Information
  45. 6.8.2 F. Hoffmann-La Roche Ltd Business Overview
  46. 6.8.3 F. Hoffmann-La Roche Ltd Bronchitis Drug Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 F. Hoffmann-La Roche Ltd Bronchitis Drug Product Portfolio
  48. 6.8.5 F. Hoffmann-La Roche Ltd Recent Developments
  49. 6.9 DBV Technologies SA
  50. 6.9.1 DBV Technologies SA Company Information
  51. 6.9.2 DBV Technologies SA Business Overview
  52. 6.9.3 DBV Technologies SA Bronchitis Drug Sales, Revenue and Gross Margin (2021-2026)
  53. 6.9.4 DBV Technologies SA Bronchitis Drug Product Portfolio
  54. 6.9.5 DBV Technologies SA Recent Developments
  55. 6.10 Advanced Inhalation Therapies (AIT) Ltd
  56. 6.10.1 Advanced Inhalation Therapies (AIT) Ltd Company Information
  57. 6.10.2 Advanced Inhalation Therapies (AIT) Ltd Business Overview
  58. 6.10.3 Advanced Inhalation Therapies (AIT) Ltd Bronchitis Drug Sales, Revenue and Gross Margin (2021-2026)
  59. 6.10.4 Advanced Inhalation Therapies (AIT) Ltd Bronchitis Drug Product Portfolio
  60. 6.10.5 Advanced Inhalation Therapies (AIT) Ltd Recent Developments
7 North America by Country
  1. 7.1 North America Bronchitis Drug Sales by Country
  2. 7.1.1 North America Bronchitis Drug Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Bronchitis Drug Sales by Country (2021-2026)
  4. 7.1.3 North America Bronchitis Drug Sales Forecast by Country (2027-2032)
  5. 7.2 North America Bronchitis Drug Market Size by Country
  6. 7.2.1 North America Bronchitis Drug Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Bronchitis Drug Market Size by Country (2021-2026)
  8. 7.2.3 North America Bronchitis Drug Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Bronchitis Drug Sales by Country
  2. 8.1.1 Europe Bronchitis Drug Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Bronchitis Drug Sales by Country (2021-2026)
  4. 8.1.3 Europe Bronchitis Drug Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Bronchitis Drug Market Size by Country
  6. 8.2.1 Europe Bronchitis Drug Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Bronchitis Drug Market Size by Country (2021-2026)
  8. 8.2.3 Europe Bronchitis Drug Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Bronchitis Drug Sales by Country
  2. 9.1.1 Asia-Pacific Bronchitis Drug Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Bronchitis Drug Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Bronchitis Drug Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Bronchitis Drug Market Size by Country
  6. 9.2.1 Asia-Pacific Bronchitis Drug Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Bronchitis Drug Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Bronchitis Drug Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Bronchitis Drug Sales by Country
  2. 10.1.1 South America Bronchitis Drug Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Bronchitis Drug Sales by Country (2021-2026)
  4. 10.1.3 South America Bronchitis Drug Sales Forecast by Country (2027-2032)
  5. 10.2 South America Bronchitis Drug Market Size by Country
  6. 10.2.1 South America Bronchitis Drug Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Bronchitis Drug Market Size by Country (2021-2026)
  8. 10.2.3 South America Bronchitis Drug Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Bronchitis Drug Sales by Country
  2. 11.1.1 Middle East and Africa Bronchitis Drug Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Bronchitis Drug Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Bronchitis Drug Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Bronchitis Drug Market Size by Country
  6. 11.2.1 Middle East and Africa Bronchitis Drug Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Bronchitis Drug Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Bronchitis Drug Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Bronchitis Drug Value Chain Analysis
  2. 12.1.1 Bronchitis Drug Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Bronchitis Drug Production Mode & Process
  7. 12.2 Bronchitis Drug Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Bronchitis Drug Distributors
  10. 12.2.3 Bronchitis Drug Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst